REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR
聚合免疫球蛋白受体的调节
基本信息
- 批准号:3459843
- 负责人:
- 金额:$ 9.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-04-01 至 1995-03-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS antibody receptor bactericidal immunity cell differentiation genetic transcription hormone regulation /control mechanism immunoglobulin A immunoglobulin genes immunoregulation interferons intestinal mucosa membrane activity messenger RNA plasmids polymers posttranscriptional RNA processing reporter genes secretory immune system transfection tumor necrosis factor alpha
项目摘要
Secretory immunoglobulin A is the first line of immune defense, protecting
the mucous membranes of the gastrointestinal and respiratory tracts against
ingested and inhaled pathogens. The transport of secretory IgA into
external fluids is mediated by the polymeric immunoglobulin receptor (poly-
Ig-R) on the surface of mucosal epithelial cells. Because of its key role
in mucosal immunity, the proposed experiments will explore the regulation
of poly-Ig-R expression in a subclone of the human HT-29 colon carcinoma
cell-line, HT-29.74, which undergoes enterocytic differentiation when
cultured in medium devoid of glucose. Expression of poly-Ig-R by HT-29.4
cells is increased dramatically during differentiation and by treatment
with cytokines such as interferon-gamma and tumor necrosis factor-alpha.
Three specific aims are proposed to determine the molecular mechanisms by
which poly-Ig-R is regulated during differentiation of intestinal
epithelial cells and by the action of specific immune modulators. First,
the effects of the immune modulators interferon-gamma and tumor necrosis
factor-alpha on steady-state levels of poly-Ig-R mRNA poly-Ig-R protein at
specific stages of differentiation of HT-29.74 cells will be determined.
Next, the contribution of transcriptional and post-transcriptional
regulation will be assessed by measuring in vitro rates of poly-Ig-R gene
transcription and stability of poly-Ig-R mRNA. Finally, specific cis-
acting DNA elements in the poly-Ig-R gene which mediate its transcriptional
regulation will be identified by 1) constructing chimeric plasmids in which
fragments of the proximal 5'-flanking region of the poly-Ig-R gene have
been inserted upstream of a reporter gene; 2) transfecting these plasmids
into HT-29.74 cells; and 3) determining the effects of enterocytic
differentiation and treatment with immune modulators on transcription of
the reporter gene. The proposed experiments offer the potential for
identifying novel regulatory mechanisms which control the differentiation-
specific and cytokine-induced expression of poly-Ig-R. In addition, the
proposed studies have the potential to add to our understanding of the
molecular mechanisms by which cytokines in general regulate immune
responses. Increased understanding of mechanisms regulating immune
responses in the gut, including the effects of interferon-gamma and tumor
necrosis factor-alpha, may offer new insights that could lead to better
prevention and treatment of infectious diseases of mucosal surfaces,
including AIDS.
分泌型免疫球蛋白A是免疫防御的第一道防线,
胃肠道和呼吸道的粘膜,
摄入和吸入的病原体。 分泌型伊加转运到
外部流体是由多聚免疫球蛋白受体(多聚
Ig-R)在粘膜上皮细胞表面的表达。 由于其关键作用
在粘膜免疫中,拟议的实验将探索调节
人HT-29结肠癌亚克隆中poly-Ig-R表达的研究
细胞系HT-29.74,其在以下情况下经历肠细胞分化:
在没有葡萄糖的培养基中培养。 HT-29.4表达poly-Ig-R
细胞在分化过程中显著增加,
用细胞因子如干扰素-γ和肿瘤坏死因子-α。
提出了三个具体的目标,以确定分子机制,
其中poly-Ig-R在肠上皮细胞分化过程中受到调节,
上皮细胞和通过特异性免疫调节剂的作用。 第一、
免疫调节剂干扰素-γ和肿瘤坏死的影响
α因子对聚-Ig-R mRNA聚-Ig-R蛋白稳态水平的影响
将确定HT-29.74细胞分化的特定阶段。
接下来,转录和转录后的贡献
将通过测量多聚-Ig-R基因的体外速率来评估调节
转录和稳定性。 最后,具体的顺-
在poly-Ig-R基因中的作用DNA元件,其介导其转录
调控将通过1)构建嵌合质粒来鉴定,其中
聚-Ig-R基因的近端5 ′-侧翼区的片段具有
插入到报告基因的上游; 2)分离这些质粒
HT-29.74细胞;和3)确定肠细胞的作用
分化和用免疫调节剂治疗对转录的影响
报告基因。 拟议的实验提供了潜在的
确定控制分化的新的调节机制-
特异性和甘氨酸诱导的poly-Ig-R表达。 此外该
拟议的研究有可能增加我们对
细胞因子一般调节免疫的分子机制
应答 增强对免疫调节机制的理解
肠道反应,包括干扰素-γ和肿瘤的影响
坏死因子-α,可能提供新的见解,可能导致更好的
预防和治疗粘膜表面的感染性疾病,
包括艾滋病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charlotte S Kaetzel其他文献
Charlotte S Kaetzel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charlotte S Kaetzel', 18)}}的其他基金
Novel in vivo models for cell-type specific MyD88 signaling in the intestine
肠道细胞类型特异性 MyD88 信号传导的新型体内模型
- 批准号:
7933489 - 财政年份:2009
- 资助金额:
$ 9.15万 - 项目类别:
Novel in vivo models for cell-type specific MyD88 signaling in the intestine
肠道细胞类型特异性 MyD88 信号传导的新型体内模型
- 批准号:
7497566 - 财政年份:2007
- 资助金额:
$ 9.15万 - 项目类别:
Novel in vivo models for cell-type specific MyD88 signaling in the intestine
肠道细胞类型特异性 MyD88 信号传导的新型体内模型
- 批准号:
7201872 - 财政年份:2007
- 资助金额:
$ 9.15万 - 项目类别:
REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR
聚合免疫球蛋白受体的调节
- 批准号:
3459846 - 财政年份:1990
- 资助金额:
$ 9.15万 - 项目类别:
REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR
聚合免疫球蛋白受体的调节
- 批准号:
3459844 - 财政年份:1990
- 资助金额:
$ 9.15万 - 项目类别:
REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR
聚合免疫球蛋白受体的调节
- 批准号:
2683498 - 财政年份:1990
- 资助金额:
$ 9.15万 - 项目类别:
REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR
聚合免疫球蛋白受体的调节
- 批准号:
6497649 - 财政年份:1990
- 资助金额:
$ 9.15万 - 项目类别:
REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR
聚合免疫球蛋白受体的调节
- 批准号:
6350096 - 财政年份:1990
- 资助金额:
$ 9.15万 - 项目类别:
REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR
聚合免疫球蛋白受体的调节
- 批准号:
6628260 - 财政年份:1990
- 资助金额:
$ 9.15万 - 项目类别:
REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR
聚合免疫球蛋白受体的调节
- 批准号:
2094522 - 财政年份:1990
- 资助金额:
$ 9.15万 - 项目类别:
相似海外基金
Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
- 批准号:
23H02361 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : GNT1124162 - 财政年份:2017
- 资助金额:
$ 9.15万 - 项目类别:
Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : 1124162 - 财政年份:2017
- 资助金额:
$ 9.15万 - 项目类别:
Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9300976 - 财政年份:2015
- 资助金额:
$ 9.15万 - 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9920805 - 财政年份:2015
- 资助金额:
$ 9.15万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8900121 - 财政年份:2012
- 资助金额:
$ 9.15万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8225814 - 财政年份:2012
- 资助金额:
$ 9.15万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8699511 - 财政年份:2012
- 资助金额:
$ 9.15万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8525355 - 财政年份:2012
- 资助金额:
$ 9.15万 - 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
- 批准号:
9115537 - 财政年份:1991
- 资助金额:
$ 9.15万 - 项目类别:
Standard Grant